These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15501808)

  • 21. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
    Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
    J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
    Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
    Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation.
    Pettersson J; Holmström A; Hill J; Leary S; Frithz-Lindsten E; von Euler-Matell A; Carlsson E; Titball R; Forsberg A; Wolf-Watz H
    Mol Microbiol; 1999 Jun; 32(5):961-76. PubMed ID: 10361299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
    Fahlgren A; Westermark L; Akopyan K; Fällman M
    Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
    Logsdon LK; Mecsas J
    Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A putative DNA adenine methyltransferase is involved in Yersinia pseudotuberculosis pathogenicity.
    Pouillot F; Fayolle C; Carniel E
    Microbiology (Reading); 2007 Aug; 153(Pt 8):2426-2434. PubMed ID: 17660407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.
    Nilles ML; Fields KA; Straley SC
    J Bacteriol; 1998 Jul; 180(13):3410-20. PubMed ID: 9642196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.
    Sing A; Reithmeier-Rost D; Granfors K; Hill J; Roggenkamp A; Heesemann J
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16049-54. PubMed ID: 16239347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
    Fisher ML; Castillo C; Mecsas J
    Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
    Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J
    Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis.
    Aili M; Isaksson EL; Hallberg B; Wolf-Watz H; Rosqvist R
    Cell Microbiol; 2006 Jun; 8(6):1020-33. PubMed ID: 16681842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virulence role of V antigen of Yersinia pestis at the bacterial surface.
    Fields KA; Nilles ML; Cowan C; Straley SC
    Infect Immun; 1999 Oct; 67(10):5395-408. PubMed ID: 10496922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa.
    Bröms JE; Sundin C; Francis MS; Forsberg A
    J Infect Dis; 2003 Jul; 188(2):239-49. PubMed ID: 12854079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague.
    Taylor VL; Titball RW; Oyston PCF
    Microbiology (Reading); 2005 Jun; 151(Pt 6):1919-1926. PubMed ID: 15941999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of V antigen in promoting virulence in Yersiniae.
    Une T; Nakajima R; Brubaker RR
    Contrib Microbiol Immunol; 1987; 9():179-85. PubMed ID: 3665496
    [No Abstract]   [Full Text] [Related]  

  • 38. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
    Logsdon LK; Mecsas J
    Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
    González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
    PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
    Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
    PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.